Nomogram for Predicting Postoperative Portal Venous Systemic Thrombosis in Patients with Cirrhosis Undergoing Splenectomy and Esophagogastric Devascularization
Table 1
Characteristics of patients in the non-PVST and PVST groups.
Factors
Non-PVST(119)
PVST(76)
value
Preoperative
Age (years)
48.90 (10.32)
46.16 (9.26)
0.061
BMI (kg/m2)
22.60 (20.85, 24.40)
22.80 (20.90, 24.52)
0.81
Gender (%)
Female
44 (37.0)
23 (30.3)
0.419
Male
75 (63.0)
53 (69.7)
Diabetes (%)
No
107 (89.9)
70 (92.1)
0.794
Yes
12 (10.1)
6 (7.9)
Hypertension (%)
NO
114 (95.8)
76 (100.0)
0.178
Yes
5 (4.2)
0 (0.0)
Emergency (%)
No
108 (90.8)
73 (96.1)
0.266
Yes
11 (9.2)
3 (3.9)
Child-Pugh (%)
A
84 (70.6)
58 (76.3)
0.477
B
35 (29.4)
18 (23.7)
Ascites (%)
No
99 (83.2)
59 (77.6)
0.436
Yes
20 (16.8)
17 (22.4)
Bleeding history (%)
No
73 (61.3)
31 (40.8)
0.008
Yes
46 (38.7)
45 (59.2)
Cause of cirrhosis (%)
Others
29 (24.4)
26 (34.2)
0.185
HBV
90 (75.6)
50 (65.8)
The thickness of spleen (mm)
56.00(50.50, 63.50)
57.30 (53.00, 67.00)
0.099
Length of spleen (mm)
170.00(155.00, 183.50)
186.00 (165.00, 203.75)
<0.001
PVD (mm)
12.80 (12.00, 13.50)
14.75 (13.20, 16.85)
<0.001
PVV (mm/s)
17.20 (14.95, 20.10)
18.40 (14.78, 20.19)
0.27
MELD
10.00 (9.00, 12.00)
10.00 (9.00, 13.00)
0.526
WBC (103/uL)
2.18 (1.79, 2.90)
1.94 (1.52, 2.66)
0.023
RBC (106/uL)
3.42 (0.63)
3.48 (0.58)
0.537
HB (g/L)
101.97 (21.88)
93.97 (20.91)
0.012
Lymphocyte (103/uL)
0.59 (0.46, 0.82)
0.48 (0.36, 0.64)
0.001
PLT (103/uL)
38.00 (26.50, 52.50)
36.50 (28.00, 53.00)
0.713
Neutrocyte (103/uL)
1.30 (0.98, 1.83)
1.13 (0.86, 1.79)
0.176
Monocyte (103/uL)
0.20 (0.15, 0.28)
0.17 (0.14, 0.29)
0.274
PT (s)
15.30 (13.80, 16.95)
15.55 (14.57, 16.62)
0.625
APTT (s)
40.20 (34.15, 46.10)
40.50 (35.03, 45.42)
0.811
FIB (g/L)
1.67 (1.33, 2.08)
1.39 (1.20, 1.74)
0.003
TT (s)
18.30 (13.20, 21.20)
19.50 (17.08, 21.08)
0.087
HCT (%)
29.90 (26.45, 33.90)
27.95 (25.70, 31.15)
0.013
MPV (fl)
10.40 (9.55, 12.15)
10.30 (9.70, 11.62)
0.718
PDW (fl)
17.30 (15.95, 17.86)
17.16 (16.05, 18.25)
0.608
RDW (%)
15.60 (14.50, 17.35)
17.15 (14.90, 20.30)
0.002
Albumin(g/L)
36.40 (33.40, 39.35)
37.05 (34.18, 40.40)
0.262
Globin (g/L)
27.20 (22.65, 30.30)
26.45 (22.45, 28.77)
0.147
ALT (U/L)
24.70 (17.25, 32.95)
20.25 (16.05, 27.70)
0.093
AST (U/L)
29.60 (22.10, 37.45)
24.10 (20.00, 32.47)
0.011
TBIL (umol/L)
20.80 (15.00, 30.15)
20.60 (13.30, 27.42)
0.436
Postoperative
RBC
3.36 (0.58)
3.53 (0.67)
0.062
PLT
76.00 (60.50, 97.50)
83.00 (59.00, 100.00)
0.708
RDW1 (%)
15.40 (14.60, 17.05)
16.90 (15.10, 19.65)
0.004
RDW3 (%)
15.40 (14.55, 17.00)
18.65 (14.97, 21.30)
<0.001
RDW7 (%)
15.60 (14.40, 17.20)
16.00 (14.78, 19.20)
0.044
MPV1 (%)
11.30 (10.24, 12.40)
11.05 (10.30, 11.95)
0.818
MPV3 (%)
11.40 (10.07, 12.40)
11.15 (10.40, 12.70)
0.498
MPV7 (%)
10.79 (1.36)
10.94 (1.51)
0.459
PDW1 (%)
17.10 (16.18, 17.85)
17.10 (16.28, 17.92)
0.853
PDW3 (%)
16.40 (15.93, 16.95)
16.58 (15.87, 17.17)
0.443
PDW7 (%)
16.10 (15.38, 16.40)
15.90 (14.40, 16.31)
0.229
Bold indicates value < 0.05. BMI: body mass index, PVD: portal vein diameter, PVV: portal vein velocity, MELD: model for end-stage liver disease, TBIL: total bilirubin, WBCs: white blood cell, RBC: red blood cell, HB: hemoglobin, PT: prothrombin time, PLT: platelet, APTT: activated partial thromboplastin time, FIB: fibrinogen, TT: thrombin time, HCT: hematocrit, MPV: mean platelet volume, PDW: platelet distribution width, RDW: red blood cell distribution, AST: aspartate aminotransferase, and ALT: alanine aminotransferase.Numbers 1, 3, and 7 represent the factors on a postoperative day (POD) 1, 3, and 7, respectively.
